Press release
Self-amplifying RNA (saRNA) Drugs Market: Size, Share, Growth, Analysis, Key Players, Revenue, | Valuates Reports
Self-amplifying RNA (saRNA) Drugs MarketsaRNA is an RNA that shares many structural similarities with mRNA: it is a linear, single-stranded RNA molecule synthesized from a 5' cap, a 3' poly(A) tail, and 5' and 3' UTRs. The main difference is that saRNA is a larger molecule because it encodes four additional proteins in addition to the vaccine antigen or gene of interest. These four additional proteins are nonstructural proteins, usually derived from alphaviruses, encoding replicase enzymes. This replicase is able to amplify the original RNA strand upon delivery to cells, resulting in higher amounts of protein expression with minimal RNA dosage required.
The global Self-amplifying RNA (saRNA) Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Self-amplifying RNA (saRNA) Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Self-amplifying RNA (saRNA) Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Self-amplifying RNA (saRNA) Drugs include Chimeron Bio, Ziphius Vaccines, Aldevron, VaxEquity, Precision Nanosystems, Replicate Bioscience, Elixirgen Therapeutics, Immorna and CSL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Self-amplifying RNA (saRNA) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Self-amplifying RNA (saRNA) Drugs.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-6S16968/Global_Self_amplifying_RNA_saRNA_Drugs_Market_Research_Report_2024
Report Scope
The Self-amplifying RNA (saRNA) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Self-amplifying RNA (saRNA) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Self-amplifying RNA (saRNA) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-6S16968/Global_Self_amplifying_RNA_saRNA_Drugs_Market_Research_Report_2024
Segment by Type
• Preventive Medicine
• Medicine
Segment by Application
• Infectious Disease
• Cancer
• Others
By Company
Chimeron Bio, Ziphius Vaccines, Aldevron, VaxEquity, Precision Nanosystems, Replicate Bioscience, Elixirgen Therapeutics, Immorna, CSL, Arcturus Therapeutics
View full report
https://reports.valuates.com/market-reports/QYRE-Auto-6S16968/global-self-amplifying-rna-sarna-drugs
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Self-amplifying RNA (saRNA) Drugs Market: Size, Share, Growth, Analysis, Key Players, Revenue, | Valuates Reports here
News-ID: 3612514 • Views: …
More Releases from Valuates Reports
Multi-Purpose High-Pressure Cleaning Robots Market Share Expands with Automation …
Multi-Purpose High-Pressure Cleaning Robots Market Size
The global market for Multi-Purpose High-Pressure Cleaning Robots was valued at US$ 1388 million in the year 2024 and is projected to reach a revised size of US$ 2033 million by 2031, growing at a CAGR of 5.6% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-28M19834/Global_Multi_Purpose_High_Pressure_Cleaning_Robots_Market_Research_Report_2025
The Multi-Purpose High-Pressure Cleaning Robots Market is witnessing accelerated market growth driven by rising demand for automated industrial maintenance, labor cost reduction,…
Unmanned Aerial Vehicles (UAVs) Market Share Expands with Rising Commercial Adop …
Unmanned Aerial Vehicles (UAVs) - Market Size
The global market for Unmanned Aerial Vehicles (UAVs) was estimated to be worth US$ 6485 million in 2023 and is forecast to a readjusted size of US$ 16630 million by 2030 with a CAGR of 14.3% during the forecast period 2024-2030
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-6T3359/Global_Unmanned_Aerial_Vehicles_UAVs_Market_Insights_and_Forecast_to_2026
The Unmanned Aerial Vehicles (UAVs) Market is witnessing substantial market growth driven by expanding commercial applications, technological advancements in autonomous flight systems,…
Fixed Wing Unmanned Aerial Vehicles Market Share Expands with Growing Defense Mo …
Fixed Wing Unmanned Aerial Vehicles Market Size
The global market for Fixed Wing Unmanned Aerial Vehicles was valued at US$ 1657 million in the year 2024 and is projected to reach a revised size of US$ 2864 million by 2031, growing at a CAGR of 8.3% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-28I2001/Global_Fixed_Wing_Unmanned_Aerial_Vehicles_Market_Insights_Forecast_to_2028
The Fixed Wing Unmanned Aerial Vehicles (UAV) Market is experiencing robust market growth driven by increasing defense modernization programs, expanding…
CVD SiC Market Share Accelerates with Semiconductor Equipment Demand and Advance …
CVD SiC Market Size
The global CVD SiC market is projected to grow from US$ 420.6 million in 2024 to US$ 620.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-93/Global_CVD_SiC_Market_Insights_and_Forecast_to_2028
The CVD SiC Market is witnessing strong market growth driven by expanding semiconductor manufacturing, rising demand for power electronics, and increasing adoption of silicon carbide (SiC) materials in advanced wafer fabrication equipment.…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
